Home Infusion Therapy Market

Home Infusion Therapy Market Size

Home Infusion Therapy Market size was valued at USD 31.9 billion in 2023 and is expected to exhibit growth at a CAGR of 11% from 2024 to 2032. High market growth can be attributed to ongoing advancements in infusion technology, the rising prevalence of chronic diseases, favorable reimbursement policies, and increasing patient preference for home-based care, among other contributing factors.

Moreover, chronic diseases such as diabetes, cancer, and cardiovascular conditions are on the rise globally. For instance, as per the data reported by Centers for Disease Control and Prevention (CDC), around 805,000 people suffer from heart attack every year in the U.S. Additionally, 1 in every 5 persons in the U.S. or around 695,000 people died from heart diseases in 2021. Therefore, these conditions often require long-term treatment and management, which can be effectively provided through home infusion therapy. The convenience and comfort of receiving therapy at home, without frequent hospital visits, significantly enhance patient adherence and outcomes.

Furthermore, home infusion therapy is often more cost-effective compared to inpatient care. It reduces hospital stay durations and associated healthcare costs, including bed occupancy and healthcare worker time. This cost-efficiency is appealing to both healthcare systems and patients, driving the market growth.

Home infusion therapy involves the administration of medications and biologicals intravenously or through other non-oral routes, such as subcutaneously, in a patient’s home. This therapy is designed to treat a wide range of medical conditions, including infections, dehydration, gastrointestinal diseases, and chronic diseases requiring long-term drug administration.

Home Infusion Therapy Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous innovations in technology, growing demand for integrated telehealth services, rising demand for chronic disease management and expansion of home healthcare services, among other factors are propelling the industry growth.

• Advancements in infusion technology, such as the development of portable and user-friendly intravenous infusion pump, are making home infusion therapy more accessible and efficient. Modern devices feature remote monitoring, automatic drug delivery adjustments, and enhanced safety mechanisms, ensuring precise and reliable treatment.
  
• Further, there is a growing trend among patients to prefer home-based care over traditional hospital-based treatments. Factors such as the comfort of being at home, the ability to maintain normal daily activities, and the presence of family support contribute to this preference, thereby driving the demand for home infusion therapy.
  

Home Infusion Therapy Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on product, the market is classified into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pumps generated the highest revenue of around USD 16 billion in 2023.

• The global aging population is driving the need for home-based medical care, including infusion therapy. Elderly patients often have multiple chronic conditions that require regular administration of medications and nutrients.
  
• Infusion pumps allow these patients to receive necessary treatments at home, reducing the need for frequent hospital visits and improving their comfort and convenience.
  
• Moreover, the development of new drug formulations that are suitable for home infusion therapy is driving the demand for infusion pumps. Biologics, specialty drugs, and personalized medicine treatments often require precise and controlled administration, which is facilitated by advanced infusion pumps, thereby leading to the segment growth.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the home infusion therapy market is classified into anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and other applications. The anti-infective segment dominated the market in 2023 with a market share of 27%.

• The rising incidence of bacterial, viral, and fungal infections, including those resistant to standard oral antibiotics, necessitates the use of potent anti-infective agents administered intravenously.
  
• Conditions such as sepsis, osteomyelitis, complicated urinary tract infections, and certain respiratory infections often require prolonged intravenous antibiotic therapy, which can be effectively managed through home infusion.
  
• Furthermore, the integration of telehealth services with home infusion therapy enhances patient monitoring and support. Healthcare providers can remotely oversee the administration of anti-infective agents, offer real-time guidance, and promptly address any complications, ensuring the safe and effective management of infections at home.
  

Looking for region specific data?

Download Free PDF

North America home infusion therapy market accounted for USD 13.8 billion market revenue in 2023 and is anticipated to grow at CAGR of 10.3% between 2024 – 2032 period.

• Increasing healthcare expenditure in the region is driving the adoption of cost-effective and efficient healthcare solutions like home infusion therapy. The shift towards value-based care models focuses on improving patient outcomes while reducing healthcare costs, which aligns with the benefits offered by home infusion therapy.
  
• Moreover, collaborations between healthcare providers, technology companies, and pharmaceutical firms are driving innovation in infusion therapies. These partnerships are leading to the development of more advanced and user-friendly infusion devices, expanding the market for home infusion therapy.
  

Germany home infusion therapy market is projected to grow remarkably in the coming years.

• Germany has a robust healthcare system with comprehensive health insurance coverage, including statutory health insurance (SHI) and private health insurance (PHI). Favorable reimbursement policies for home infusion therapy make these services more accessible and affordable for patients, driving market growth
  
• Further, there is a growing expansion of home healthcare services in the country, with healthcare providers increasingly offering specialized home infusion therapy as part of their service portfolios. This expansion is supported by investments in healthcare infrastructure and the development of new service models to meet the needs of home-based patients.
  

Japan holds a dominant position in the Asia Pacific home infusion therapy market.

• Japan has one of the oldest populations in the world, with a substantial portion of its citizens aged 65 and older. This demographic trend leads to a higher prevalence of age-related chronic conditions such as diabetes, cardiovascular diseases, and cancer, which often require long-term medical treatments.
  
• Home infusion therapy provides a convenient and effective solution for managing these conditions, enabling elderly patients to receive necessary treatments at home. This is expected to boost the market growth in the country.
  

Home Infusion Therapy Market Share

The market is characterized by a mix of established healthcare providers, pharmaceutical companies, and specialized home healthcare service providers. These companies offer a wide range of infusion therapies and services, leveraging economies of scale and comprehensive patient care solutions. Additionally, pharmaceutical firms like Fresenius Kabi and B. Braun Melsungen AG play significant roles by supplying infusion products and collaborating with healthcare providers to expand their market footprint. The market is also witnessing increased competition from regional players and new entrants focusing on technological innovations, personalized patient care, and strategic partnerships to differentiate their offerings and capture market share in this rapidly growing segment of healthcare delivery.

Home Infusion Therapy Market Companies

Prominent players operating in the home infusion therapy industry include:

• AMERITA INC.
• Amsino International, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Contec Medical Systems Co. Ltd
• Erenler Medikal
• Fresenius Kabi
• Halyard Health, Inc. (Avanos Medical)
• ICU Medical Inc.
• JMS Co. Ltd.
• Lepu Medical Technology
• Moog Inc.
• Option Care Health, Inc.
• Terumo Corporation
  

Home Infusion Therapy Industry News:

• In February 2024, Dynamic Access, LLC announced the launch of Dynamic Infusion, a new affiliate brand offering home infusion nursing services to patients with chronic diseases such as autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, multiple sclerosis, and others. This new brand will support the operations of two heritage firms, each with over ten years of expertise in providing home infusion nursing services to patients throughout the Northeast.
  
• In April 2024, Baxter International Inc. announced that its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software received 510(k) approval from the U.S. Food and Drug Administration. This approval allows clinicians to use a single, integrated system across a wide range of patient care settings. Offering the Novum IQ LVP in the U.S. underscores Baxter's commitment to ongoing innovation in infusion treatment.
  

The home infusion therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Infusion pumps
• Intravenous sets
• IV cannulas
• Needleless connectors

Market, By Application

• Anti-infective
• Hydration therapy
• Chemotherapy
• Enteral nutrition
• Parenteral nutrition
• Specialty pharmaceuticals
• Other applications

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa